Eris Biotech
New accelerator entry · 2024-01-26 · the record
In their words
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Eris Biotech
- Source Check — verify what Eris Biotech states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Eris Biotech for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Eris BiotechYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Eris Biotech: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.